Anvisa

Anvisa, established in 1999, serves as a critical regulatory body within the government sector. The organization focuses on the rigorous oversight of health-related products and services, ensuring that safety standards are maintained across various industries. By implementing continuous safety control processes, Anvisa plays a pivotal role in monitoring substances and pharmaceutical products that impact public health. The agency is committed to global regulatory alignment, advocating for the revision of rules concerning anorexigenic substances to mitigate risks associated with their consumption. Its mandate extends to the comprehensive evaluation of health risks, providing a framework that governs the approval and monitoring of medical products.

Operating with a workforce of 1,000-5,000 employees, Anvisa maintains a robust operational structure to support its regulatory functions. The agency manages its activities across 2 locations, ensuring effective oversight and administrative reach. Meet Anvisa's team to understand the organizational structure and the professional expertise driving these regulatory initiatives. The agency's operational model is designed to handle complex health data, facilitating efficient decision-making processes that protect the population. By leveraging internal technical expertise, the organization maintains high standards of compliance and safety, which are essential for the effective management of public health policies and the enforcement of national health regulations.

With an annual revenue of $296.3M, Anvisa demonstrates significant fiscal capacity to support its extensive regulatory operations. The agency’s work is characterized by a commitment to transparency and scientific rigor, often collaborating with international bodies to harmonize safety protocols. Its strategic focus includes the management of B2B and B2C health sectors,View more...